Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
Yamashita T, Ikeda T, Akita Y.
J Cardiol. 2019 May;73(5):386-393. doi: 10.1016/j.jjcc.2018.11.009.

EFFECT OF HYDROPHILIC AND HYDROPHOBIC POLYMER ON IN VITRO DISSOLUTION AND PERMEATION OF BISOPROLOL FUMARATE THROUGH TRANSDERMAL PATCH.
Shabbir M, Ali S, Raza M, Sharif A, Akhtar FM, Manan A, Fazli AR, Younas N, Manzoor I.
Acta Pol Pharm. 2017 Jan;74(1):187-197.

Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
Sairaku A, Nakano Y, Shiode N, Suenari K, Oda N, Ono K, Kihara Y.
Cardiovasc Ther. 2018 Jun;36(3):e12325. doi: 10.1111/1755-5922.12325.

Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
Momomura SI, Saito Y, Yasumura Y, Yamamoto K, Sakata Y, Daimon M, Kinugawa K, Okamoto H, Dohi N, Komuro I.
Circ J. 2017 Dec 25;82(1):141-147. doi: 10.1253/circj.CJ-17-0532.

IN VITRO TESTING OF XANTHAN/LIGNIN HYDROGELS AS CARRIERS FOR CONTROLLED DELIVERY OF BISOPROLOL FUMARATE.
Răschip IE, Panainte AD, Pamfil D, Profire L, Vasile C.
Rev Med Chir Soc Med Nat Iasi. 2015 Oct-Dec;119(4):1189-94.

Preparation of bisoprolol fumarate nasal spray and its nasal delivery in rats.
Fugen G, Duo H, Gendalai M, Chunzhi W, Yi W.
Pak J Pharm Sci. 2015 Nov;28(6):2173-8.

Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.
Matsuoka H, Kuwajima I, Shimada K, Mitamura H, Saruta T.
J Clin Hypertens (Greenwich). 2013 Nov;15(11):806-14. doi: 10.1111/jch.12208.

Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
Hori M, Nagai R, Izumi T, Matsuzaki M.
Heart Vessels. 2014 Mar;29(2):238-47. doi: 10.1007/s00380-013-0340-3.